Login / Signup

Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT).

Kaitlyn HowdenPatrick J McDonaldColin KazinaAnnie OngBen HoAnnie HuangBrent A OrrMagimairajan Issai Vanan
Published in: Neuro-oncology advances (2022)
Keyphrases
  • combination therapy
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • multiple myeloma
  • hodgkin lymphoma
  • open label
  • clinical trial
  • replacement therapy
  • study protocol